Henan Cancer Hospital: Small Cell Lung Carcinoma trials

The registry lists 12 Small Cell Lung Carcinoma studies with Henan Cancer Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 10No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLCRecruitingNCT07244016
• A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung CancerRecruitingNCT06406673Phase 2
• Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung CancerRecruitingNCT06406660Not applicable
• Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung CancerNot yet recruitingNCT06236997Phase 2
• First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic RadiotherapyStatus unknownNCT06586697Phase 2
• Utidelone in Third-line and Above Treatment of Small Cell Lung CancerStatus unknownNCT05299255Phase 2
• Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung CancerStatus unknownNCT04901754Phase 2
• Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerCompletedNCT04660097Phase 2
• Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLCCompletedNCT04055792Phase 2
• Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung CancerStatus unknownNCT03983759Phase 2
• SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung CancerStatus unknownNCT03755115Phase 2
• Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung CancerStatus unknownNCT03389087Phase 2